EurekAlert! -
9 Nov 2020 07:00
(JAMA Network) This randomized trial compares the effects of hydroxychloroquine versus placebo on patients' clinical status at 14 days (home, requiring noninvasive or invasive ventilation or extracorporeal membrane oxygenation, hospitalized, died) among adults hospitalized with COVID-19.
Share this Article